| Factor Information | |
|---|---|
| Data ID | 1993 |
| Factor | Hypoxaemia percent(male patients) |
| Description | N/A |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To ascertain if hyperuricaemia is associated with traditional cardiovascular risk factors such as dyslipidaemia. |
| p Value | <0.001 |
| Conclusion | Male congenital heart disease patients with high serum uric acid concentrations (>7 mg/dl) showed significantly (P<0.05) higher body mass index, serum creatinine, total cholesterol, low-density lipoprotein-cholesterol, triglycerides, and C-reactive protein concentrations than those male congenital heart disease patients with lower serum uric acid levels (≤7 mg/dl) |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 575 |
| CHD Type | isolated CHD |
| CHD Subtype | VSD/TOF/ASD/CoA/PS/AVSD/TGA/AS/BAV/DORV/UVH/EA/PA/Ductus/TA/PTA/SAM/MVP/PVA/other |
| Reference | |
|---|---|
| PMID | 24702708 |
| Year | 2015 |
| Title | Hyperuricaemia in congenital heart disease patients |
| Sample | ||
|---|---|---|
| Population | adults | |
| Source | blood | |
| Region | Canaria, Spain | |
| Method | spectro-photometry, immunoassay | |
| Race | European | |
| Disease History | hypoxaemia | |
| Treatment History | N/A | |
| Group | serum uric acid≤7.0mg/dl(Treatment) | serum uric acid>7.0mg/dl(Control) |
| Number | 9 | 10 |
| Age | 30.8 6±13.6 years | 35.3 ±14.2 years |
| Gender (Male: Female) | 9:0 | 10:0 |
| Marker Level | 0.056 | 0.333 |
